Neuroprotection by flavonoids.

The high morbidity, high socioeconomic costs and lack of specific treatments are key factors that define the relevance of brain pathology for human health and the importance of research on neuronal protective agents. Epidemiological studies have shown beneficial effects of flavonoids on arteriosclerosis-related pathology in general and neurodegeneration in particular. Flavonoids can protect the brain by their ability to modulate intracellular signals promoting cellular survival. Quercetin and structurally related flavonoids (myricetin, fisetin, luteolin) showed a marked cytoprotective capacity in in vitro experimental conditions in models of predominantly apoptotic death such as that induced by medium concentrations (200 M) of H2O2 added to PC12 cells in culture. Nevertheless, quercetin did not protect substantia nigra neurons in vivo from an oxidative insult (6-hydroxydopamine), probably due to difficulties in crossing the blood-brain barrier. On the other hand, treatment of permanent focal ischemia with a lecithin/quercetin preparation decreased lesion volume, showing that preparations that help to cross the blood-brain barrier may be critical for the expression of the effects of flavonoids on the brain. The hypothesis is advanced that a group of quercetin-related flavonoids could become lead molecules for the development of neuroprotective compounds with multitarget anti-ischemic effects.

[1]  F. Blasina,et al.  Cytoprotection by Achyrocline satureioides (Lam) D.C. and some of its main flavonoids against oxidative stress. , 2004, Journal of ethnopharmacology.

[2]  Rui Wang,et al.  Tacrine attenuates hydrogen peroxide-induced apoptosis by regulating expression of apoptosis-related genes in rat PC12 cells. , 2002, Brain research. Molecular brain research.

[3]  C. Rice-Evans,et al.  MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide , 2002, Neurobiology of Aging.

[4]  R. Quirion,et al.  Natural extracts as possible protective agents of brain aging , 2002, Neurobiology of Aging.

[5]  E. Esposito,et al.  A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes , 2002, Neurobiology of Aging.

[6]  K. I. Maynard,et al.  Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague‐Dawley rats , 2002, Journal of neuroscience research.

[7]  J. Terao,et al.  Combination of lipids and emulsifiers enhances the absorption of orally administered quercetin in rats. , 2002, Journal of agricultural and food chemistry.

[8]  E. J. Oliveira,et al.  Metabolism of quercetin and kaempferol by rat hepatocytes and the identification of flavonoid glycosides in human plasma , 2002, Xenobiotica; the fate of foreign compounds in biological systems.

[9]  M. Mena,et al.  Life‐threatening parkinsonism induced by kava‐kava , 2002, Movement disorders : official journal of the Movement Disorder Society.

[10]  F. Dajas-Bailador,et al.  Antioxidant and cholinergic neuroprotective mechanisms in experimental parkinsonism. , 2002, Functional neurology.

[11]  M. Assemi,et al.  Herbs Affecting the Central Nervous System: Gingko, Kava, St. John's Wort, and Valerian , 2001, Clinical obstetrics and gynecology.

[12]  D. Colquhoun.  Nutraceuticals: vitamins and other nutrients in coronary heart disease , 2001, Current opinion in lipidology.

[13]  D. Harrison,et al.  Oxidant stress as a marker for cardiovascular events: Ox marks the spot. , 2001, Circulation.

[14]  D. Harrison,et al.  Oxidative stress and vascular damage in hypertension , 2001, Coronary artery disease.

[15]  A. Khalifa,et al.  Quercetin, coenzyme Q10, and L-canavanine as protective agents against lipid peroxidation and nitric oxide generation in endotoxin-induced shock in rat brain. , 2001, Pharmacological research.

[16]  J. Andersen,et al.  Caspase 3 inhibition attenuates hydrogen peroxide‐induced DNA fragmentation but not cell death in neuronal PC12 cells , 2001, Journal of neurochemistry.

[17]  F. Dajas,et al.  Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra 1 1 Published on the World Wide Web on 1 December 2000. , 2001, Brain Research.

[18]  J. Stamford,et al.  LY393615, a novel neuronal Ca2+ and Na+ channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemia , 2001, Brain Research.

[19]  C. Rice-Evans,et al.  Flavonoid antioxidants. , 2001, Current medicinal chemistry.

[20]  A. Crozier,et al.  Plant-derived phenolic antioxidants , 2000, Current opinion in clinical nutrition and metabolic care.

[21]  Yuzuru Ito,et al.  Activation of caspase-9 and -3 during H2O2-induced apoptosis of PC12 cells independent of ceramide formation , 2000, Neurological research.

[22]  S. Chun,et al.  In vivo antioxidant effect of green tea , 2000, European Journal of Clinical Nutrition.

[23]  P. Gluckman,et al.  Neuroprotective strategies for basal ganglia degeneration: Parkinson’s and Huntington’s diseases , 2000, Progress in Neurobiology.

[24]  D. Albanes,et al.  Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. , 1999, Stroke.

[25]  Emmert Dh,et al.  The role of vitamin E in the prevention of heart disease. , 1999 .

[26]  S. Lipton,et al.  Excitotoxins in Neuronal Apoptosis and Necrosis , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  P. Riso,et al.  Does tomato consumption effectively increase the resistance of lymphocyte DNA to oxidative damage? , 1999, The American journal of clinical nutrition.

[28]  G. Samsa,et al.  Epidemiology of recurrent cerebral infarction: a medicare claims-based comparison of first and recurrent strokes on 2-year survival and cost. , 1999, Stroke.

[29]  J. Seylaz,et al.  Influence of the antioxidant quercetin in vivo on the level of nitric oxide determined by electron paramagnetic resonance in rat brain during global ischemia and reperfusion. , 1999, Biochemical pharmacology.

[30]  D. Choi,et al.  Hypoxic-Ischemic Brain Injury and Oxidative Stress , 1999 .

[31]  J. Kirchner,et al.  The role of vitamin E in the prevention of heart disease. , 1999, Archives of family medicine.

[32]  P. Heuschmann,et al.  A prospective community-based study of stroke in Germany--the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months. , 1998, Stroke.

[33]  G. Nappi,et al.  Hydroxyl radical production in the substantia nigra after 6-hydroxydopamine and hypoxia-reoxygenation , 1998, Brain Research.

[34]  W. Frishman,et al.  Herbal medicine for the treatment of cardiovascular disease: clinical considerations. , 1998, Archives of internal medicine.

[35]  B. Juurlink,et al.  Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies. , 1998, The journal of spinal cord medicine.

[36]  S. Manenti,et al.  Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. , 1997, Biochemical pharmacology.

[37]  K. Welch.  Primer on cerebrovascular diseases , 1997 .

[38]  M. Plotkine,et al.  Short Therapeutic Window for MK-801 in Transient Focal Cerebral Ischemia in Normotensive Rats , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  A. Cross,et al.  The neuroprotective effect of chlormethiazole on ischaemic neuronal damage following permanent middle cerebral artery ischaemia in the rat. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[40]  K. Ishimura,et al.  Effects of flavonoid compounds on the activity of NADPH diaphorase prepared from the mouse brain. , 1994, Japanese journal of pharmacology.

[41]  P. Fuchs,et al.  Myricetin and quercetin, the flavonoid constituents ofGinkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca2+-loaded brain neurons , 1994, Brain Research.

[42]  W. Chang,et al.  Inhibitory effects of flavonoids on xanthine oxidase. , 1993, Anticancer research.

[43]  C. Vlahos,et al.  The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. , 1992, Biochemical and biophysical research communications.

[44]  J. Krieglstein,et al.  Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents. , 1992, European journal of pharmacology.

[45]  C. J. Alden.  NTP technical report on the toxicology and carcinogenesis studies of chlorinated water (CAS NOS. 7782-50-5 and 7681-52-9) and chloraminated water (CAS NO. 10599-90-3) (deionized and charcoal-filtered) in F344/N rats and B6C3F1 mice (drinking water studies) , 1992 .

[46]  L. Larocca,et al.  Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells. , 1990, British Journal of Cancer.

[47]  D. Attwell,et al.  The release and uptake of excitatory amino acids. , 1990, Trends in pharmacological sciences.

[48]  R A Swanson,et al.  A Semiautomated Method for Measuring Brain Infarct Volume , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[49]  T. Sakai,et al.  The effect of quercetin on cell cycle progression and growth of human gastric cancer cells , 1990, FEBS letters.

[50]  M. Dubois,et al.  Flavonoid modulation of protein kinase C activation. , 1989, Life sciences.

[51]  R. Gryglewski,et al.  On the mechanism of antithrombotic action of flavonoids. , 1987, Biochemical pharmacology.

[52]  C. Fiedler-Nagy,et al.  Effect of flavonoids on arachidonic acid metabolism. , 1986, Progress in clinical and biological research.

[53]  T. Sugimura,et al.  Inhibition of tumor promotion by flavonoids. , 1986, Progress in clinical and biological research.

[54]  F. Marks,et al.  Inhibition of the calcium- and phospholipid-dependent protein kinase activity from mouse brain cytosol by quercetin. , 1983, Biochemical and biophysical research communications.

[55]  J. Cazenave,et al.  Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin. , 1982, Biochemical pharmacology.